Evidence map›Paper›PMID 32962129›Full record

ArticleInternational journal of molecular sciences2020

Clearing of Foreign Episomal DNA from Human Cells by CRISPRa-Mediated Activation of Cytidine Deaminases.

Sergey Brezgin, Anastasiya Kostyusheva, Natalia Ponomareva, Viktoriia Volia, Irina Goptar, Anastasiya Nikiforova, Igor Shilovskiy, Valery Smirnov, Dmitry Kostyushev, Vladimir Chulanov

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Sergey BrezginDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.
Anastasiya KostyushevaDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.
Natalia PonomarevaDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.
Viktoriia VoliaDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.
Irina GoptarIzmerov Research Institute of Occupational Health, 105275 Moscow, Russia.
Anastasiya NikiforovaIzmerov Research Institute of Occupational Health, 105275 Moscow, Russia.
Igor ShilovskiyDepartment of Molecular Immunology, Institute of Immunology, Federal Medical Biological Agency, 115522 Moscow, Russia.
Valery SmirnovDepartment of Molecular Immunology, Institute of Immunology, Federal Medical Biological Agency, 115522 Moscow, Russia.
Dmitry KostyushevDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.ORCID 0000-0002-1851-7441
Vladimir ChulanovDepartment of Molecular Biology and Immunopathology of Infectious Diseases, National Medical Research Center for Tuberculosis and Infectious Diseases, 127994 Moscow, Russia.ORCID 0000-0001-6303-9293
Federal Medical-Biological Agency · RUThe Federal State Budgetary Scientific Institution "Izmerov Research Institute of Occupational Health" · RUSechenov University · RU

Funding

Russian Science Foundation 20-15-00373
6 · The paper itself

Abstract

Restriction of foreign DNA is a fundamental defense mechanism required for maintaining genomic stability and proper function of mammalian cells. APOBEC cytidine deaminases are crucial effector molecules involved in clearing pathogenic DNA of viruses and other microorganisms and improperly localized self-DNA (DNA leakages). Mastering the expression of APOBEC provides the crucial means both for developing novel therapeutic approaches for combating infectious and non-infectious diseases and for numerous research purposes. In this study, we report successful application of a CRISPRa approach to effectively and specifically overexpress APOBEC3A and APOBEC3B deaminases and describe their effects on episomal and integrated foreign DNA. This method increased target gene transcription by >6-50-fold in HEK293T cells. Furthermore, CRISPRa-mediated activation of APOBEC3A/APOBEC3B suppressed episomal but not integrated foreign DNA. Episomal GC-rich DNA was rapidly destabilized and destroyed by CRISPRa-induced APOBEC3A/APOBEC3B, while the remaining DNA templates harbored frequent deaminated nucleotides. To conclude, the CRISPRa approach could be readily utilized for manipulating innate immunity and investigating the effects of the key effector molecules on foreign nucleic acids.

Indexed as

CRISPR-Cas SystemsCytidine DeaminaseDNAHEK293 CellsHumansImmunity, InnateMinor Histocompatibility Antigensp300-CBP-Associated Factorp300-CBP Transcription FactorsPlasmidsProteinsUp-RegulationAPOBEC3A protein, humanAPOBEC3B protein, humanCytidine DeaminaseDNAMinor Histocompatibility Antigensp300-CBP-Associated Factorp300-CBP Transcription FactorsProteinsAPOBECsCRISPRacytidine deaminasesdeaminationforeign DNAinnate immunity

Identifiers

PMID32962129
PMCPMC7557733
OpenAlexW3087569299

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.